Home › Research › Brain tissue and pathology
Cerebrospinal Fluid β‐Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls
Ulf Jensen‐Kondering, Nils G. Margraf, Slaven Pikija, Kinga Rak‐Frattner, Branko Malojčić, Senta Frol, Janja Pretnar Oblak, Patricia de la Riva et al.. Journal of the American Heart Association, 2025-07-29
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The study included 25 patients with iCAA (age, 44±11 years), 31 patients with sCAA (age, 75±5 years), 28 patients with AD (age, 71±8 years) and 30 controls (age, 72±8 years) from 9 case descriptions and 1 cohort study. Amyloid β40 concentrations did not differ significantly between iCAA and the other groups. Amyloid β42 concentration was significantly higher in controls than iCAA and the other groups. The amyloid β42/40 ratio was higher in iCAA than in AD and higher in controls than sCAA and AD. Total τ concentrations were lower in controls than iCAA but did not differ significantly between iCAA, sCAA, and AD. Phosphorylated τ concentrations were not significantly different in iCAA compared with controls, significantly higher in sCAA, and highest in AD. The observation that phosphorylated τ concentrations in iCAA are not different from controls led us to the hypothesis that iCAA is characterized by amyloid plaque formation largely without concomitant phosphorylated τ aggregation, which is well compatible with most published pathologic studies.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 25 participants. Comparing cerebrospinal fluid markers, this study found phosphorylated tau concentrations in iatrogenic CAA were not significantly different from controls, unlike in sporadic CAA and Alzheimer's disease. This led to a hypothesis about how iatrogenic CAA differs, but it is a biomarker observation with no treatment implications.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jensen‐Kondering, U., Margraf, N. G., Pikija, S., Rak‐Frattner, K., Malojčić, B., Frol, S., et al. (2025). Cerebrospinal Fluid β‐Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041908
Vancouver
Jensen‐Kondering U, Margraf NG, Pikija S, Rak‐Frattner K, Malojčić B, Frol S, et al. Cerebrospinal Fluid β‐Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041908. PMID: 40728175.
BibTeX
@article{jensenkondering2025-40728175,
author = {Jensen‐Kondering, Ulf and Margraf, Nils G. and Pikija, Slaven and Rak‐Frattner, Kinga and Malojčić, Branko and Frol, Senta and Oblak, Janja Pretnar and de la Riva, Patricia and others},
title = {{Cerebrospinal Fluid β‐Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls}},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.041908},
pmid = {40728175},
url = {https://doi.org/10.1161/jaha.125.041908}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The study included 25 patients with iCAA (age, 44±11 years), 31 patients with sCAA (age, 75±5 years), 28 patients with AD (age, 71±8 years) and 30 controls (age, 72±8 years) from 9 case descriptions and 1 cohort study.
- Amyloid β40 concentrations did not differ significantly between iCAA and the other groups.
- Amyloid β42 concentration was significantly higher in controls than iCAA and the other groups.
- The amyloid β42/40 ratio was higher in iCAA than in AD and higher in controls than sCAA and AD.
- Total τ concentrations were lower in controls than iCAA but did not differ significantly between iCAA, sCAA, and AD.
Why it matters
Comparing cerebrospinal fluid markers, this study found phosphorylated tau concentrations in iatrogenic CAA were not significantly different from controls, unlike in sporadic CAA and Alzheimer's disease. This led to a hypothesis about how iatrogenic CAA differs, but it is a biomarker observation with no treatment implications.
Study details
- Study designcohort study
- Participants25
- Evidence strengthModerate
How this study scored 49/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the American Heart Association) |
| Journal's citation record | 2 / 4 | Journal of the American Heart Association: journal h-index 200 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 25 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Benedetta Storti: h-index 12 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Christian-Albrechts-Universität zu Kiel: institution h-index 779 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 13 institution(s) in 6 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40728175) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1161/jaha.125.041908
- PubMed: 40728175
- Original source →
- Free full text: Journal of the American Heart Association →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Brain tissue and pathology from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.